Vermeire, Séverine

A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis

Machiels, K., Joossens, M., Sabino, J., De Preter, V., Arijs, I., Eeckhaut, V., Ballet, V., Claes, K., Van Immerseel, F., Verbeke, K., et al. (2014) · Gut

Gut microbiota and healthInflammatory Bowel Disease

Cited by 1,904

Quantitative microbiome profiling links gut community variation to microbial load

Vandeputte, D., Kathagen, G., D’hoe, K., Vieira-Silva, S., Valles-Colomer, M., Sabino, J., Wang, J., Tito, R. Y., De Commer, L., Darzi, Y., et al. (2017) · Nature

Gut microbiota and healthMicrobial Community Ecology and Physiology

Cited by 1,218

Dysbiosis of the faecal microbiota in patients with Crohn’s disease and their unaffected relatives

Joossens, M., Huys, G., Cnockaert, M., De Preter, V., Verbeke, K., Rutgeerts, P., Vandamme, P., & Vermeire, S. (2011) · Gut

Gut microbiota and healthInflammatory Bowel Disease

Cited by 1,063

Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial

Vermeire, S., Schreiber, S., Petryka, R., Kuehbacher, T., Hebuterne, X., Roblin, X., Klopocka, M., Goldis, A., Wisniewska-Jarosinska, M., Baranovsky, A., et al. (2017) · The Lancet

Inflammatory Bowel DiseaseRheumatoid Arthritis Research and Therapies

Cited by 439

Histamine Receptor H1–Mediated Sensitization of TRPV1 Mediates Visceral Hypersensitivity and Symptoms in Patients With Irritable Bowel Syndrome

Wouters, M. M., Balemans, D., Van Wanrooy, S., Dooley, J., Cibert-Goton, V., Alpizar, Y. A., Valdez-Morales, E. E., Nasser, Y., Van Veldhoven, P. P., Vanbrabant, W., et al. (2016) · Gastroenterology

Gastrointestinal motility and disordersIon Channels and Receptors

Cited by 372

Predicting relapse in Crohn’s disease: a biopsychosocial model

Bitton, A., Dobkin, P. L., Edwardes, M. D., Sewitch, M. J., Meddings, J. B., Rawal, S., Cohen, A., Vermeire, S., Dufresne, L., Franchimont, D., et al. (2008) · Gut

Inflammatory Bowel DiseaseOcular Diseases and Behçet’s Syndrome

Cited by 254

The impact of major depressive disorder on the short‐ and long‐term outcome of Crohn's disease treatment with infliximab

PERSOONS, P., VERMEIRE, S., DEMYTTENAERE, K., FISCHLER, B., VANDENBERGHE, J., VAN OUDENHOVE, L., PIERIK, M., HLAVATY, T., VAN ASSCHE, G., NOMAN, M., et al. (2005) · Alimentary Pharmacology & Therapeutics

Inflammatory Bowel DiseaseRheumatoid Arthritis Research and Therapies

Cited by 253

Big data in IBD: big progress for clinical practice

Seyed Tabib, N. S., Madgwick, M., Sudhakar, P., Verstockt, B., Korcsmaros, T., & Vermeire, S. (2020) · Gut

Inflammatory Bowel DiseaseArtificial Intelligence in Healthcare

Cited by 223

Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn’s disease (ANDANTE I and II)

Danese, S., Vermeire, S., Hellstern, P., Panaccione, R., Rogler, G., Fraser, G., Kohn, A., Desreumaux, P., Leong, R. W., Comer, G. M., et al. (2019) · Gut

Inflammatory Bowel DiseaseRheumatoid Arthritis Research and Therapies

Cited by 181

Inflammatory bowel disease and Parkinson’s disease: common pathophysiological links

Lee, H.-S., Lobbestael, E., Vermeire, S., Sabino, J., & Cleynen, I. (2021) · Gut

Parkinson's Disease Mechanisms and TreatmentsInflammatory Bowel Disease

Cited by 151

The role of C-reactive protein as an inflammatory marker in gastrointestinal diseases

Vermeire, S., Van Assche, G., & Rutgeerts, P. (2005) · Nature Clinical Practice Gastroenterology & Hepatology

Inflammatory Bowel DiseaseBiomarkers in Disease Mechanisms

Cited by 149

The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease

Lopetuso, L. R., Deleu, S., Godny, L., Petito, V., Puca, P., Facciotti, F., Sokol, H., Ianiro, G., Masucci, L., Abreu, M., et al. (2023) · Gut

Inflammatory Bowel DiseaseGut microbiota and health

Cited by 129

Patients with large‐duct primary sclerosing cholangitis and Crohn's disease have a better outcome than those with ulcerative colitis, or without IBD

Fevery, J., Van Steenbergen, W., Van Pelt, J., Laleman, W., Hoffman, I., Geboes, K., Vermeire, S., & Nevens, F. (2016) · Alimentary Pharmacology & Therapeutics

Liver Diseases and ImmunityInflammatory Bowel Disease

Cited by 61

Anxiety is associated with impaired tolerance of colonoscopy preparation in inflammatory bowel disease and controls

Bessissow, T., Van Keerberghen, C.-A., Van Oudenhove, L., Ferrante, M., Vermeire, S., Rutgeerts, P., & Van Assche, G. (2013) · Journal of Crohn's and Colitis

Colorectal Cancer Screening and DetectionInflammatory Bowel Disease

Cited by 53

Understanding the molecular drivers of disease heterogeneity in Crohn's disease using multi-omic data integration and network analysis

Sudhakar, P., Verstockt, B., Cremer, J., Verstockt, S., Sabino, J., Ferrante, M., & Vermeire, S. (2021) · Inflammatory Bowel Diseases

Inflammatory Bowel DiseaseGut microbiota and health

Cited by 49

Effect of 5-Hydroxytryptophan on Fatigue in Quiescent Inflammatory Bowel Disease: A Randomized Controlled Trial

Truyens, M., Lobatón, T., Ferrante, M., Bossuyt, P., Vermeire, S., Pouillon, L., Dewint, P., Cremer, A., Peeters, H., Lambrecht, G., et al. (2022) · Gastroenterology

Inflammatory Bowel DiseaseTryptophan and brain disorders

Cited by 48

Scoring endoscopic disease activity in IBD: artificial intelligence sees more and better than we do

Bossuyt, P., Vermeire, S., & Bisschops, R. (2020) · Gut

Inflammatory Bowel DiseaseRadiomics and Machine Learning in Medical Imaging

Cited by 24

Effect of Five Dietary Emulsifiers on Inflammation, Permeability, and the Gut Microbiome: A Placebo-controlled Randomized Trial

Wellens, J., Vanderstappen, J., Hoekx, S., Vissers, E., Luppens, M., Van Elst, L., Lenfant, M., Raes, J., Derrien, M., Verstockt, B., et al. (2026) · Clinical Gastroenterology and Hepatology

Gut microbiota and healthGastrointestinal motility and disorders

Cited by 17